Table 4.

Upper limit of parathyroid hormone target levels as reported by dialysis unit medical directors

Phase and Region	N facility	Upper Limit of Parathyroid Hormone Target Level
		Median	50–199 (%)	200–299 (%)	300–399 (%)	400–599 (%)	600+ (%)
EUR-A/NZ
2	122	233	26.2	41.8	15.6	13.1	3.3
3	139	300	11.5	24.5	53.2	5.0	5.8
4	142	300	5.6	13.4	43.0	23.9	14.1
5	108	450	4.6	6.5	28.7	36.1	24.1
Japan
2	54	300	5.6	42.6	35.2	14.8	1.9
3	60	300	21.7	23.3	43.3	6.7	5.0
4	56	180	60.7	21.4	8.9	1.8	7.1
5	57	300	3.5	43.9	43.9	8.8	0
North America
1a	77	250	6.5	50.6	39.0	1.3	2.6
2	75	250	30.7	32.0	28.0	8.0	1.3
3	77	300	24.7	14.3	58.4	2.6	0
4	130	300	1.5	4.6	73.8	8.5	11.5
5	84	500	1.2	0	33.3	22.6	42.9

Dialysis Outcomes and Practice Patterns Study (DOPPS) phase 1: 1996–2001; phase 2: 2002–2004; phase 3: 2005–2008; phase 4: 2009–2011. Eur-A/NZ, Australia, Belgium, France, Germany, Italy, New Zealand, Spain, Sweden, and the United Kingdom; North America, Canada and the United States.

^aData on parathyroid hormone targets in DOPPS 1 were collected in the United States only.